Investors

• Financial Results
• Investor Events
• Integrated Report
• Corporate Strategy
• ESG

• Nov. 07, 2025 InfoSecond Quarter Financial Results for Fiscal Year 2026
• Nov. 07, 2025 InfoNotice Regarding the Formulation of the Corporate Strategy 
• Nov. 07, 2025 InfoNotice: Concerning Change of Representative Executive Officer and Executive Officer 
• Nov. 07, 2025 InfoNotice Regarding Global Personnel Optimization 
• Nov. 04, 2025 InfoNotice Regarding Completion of Share Repurchase and Cancellation of Treasury Shares 

View All

• Management Policies
  • Corporate Philosophy
  • Corporate Strategy
  • Top Management
  • Articles of Incorporation and Share Handling Regulations
  • Disclosure Policy
  • Business Risks
  • Company Presentation
• IR Library
  • Financial Results
  • Investor Events
  • Corporate Disclosure
  • Securities Reports
  • Integrated Report
  • Olympus Medical Business
• Stock Information
  • Shareholders' Information
  • General Meeting of Shareholders
  • Shareholder Returns
  • Corporate Bonds and Ratings
  • Analyst Coverage
• Financial Data
  • Annual Data
  • Quarterly Data
  • Download Financial Data
• ESG
  • Olympus Group ESG
  • Environment
  • Social
  • Governance
• About Us
  • Olympus’ Value Creation Model
  • Fact Sheet
  • About Olympus

Annual Schedule

* The schedule may be subject to change.

• Internet IR Commendation Award 2024 by Daiwa Investor Relations Co. Ltd.
• AAA Website, All Japanese Listed Companies' Website Ranking 2024, Overall and Sector by Nikko Investor Relations Co.,Ltd.